Electrochemiluminescent Bridging Immunoassay
Assessing the unexpected loss of response to therapy with vedolizumab over time.
An aid to achieving desired serum levels of vedolizumab.
Vedolizumab lower limit of quantitation=2.0 mcg/mL
Antibodies-To-Vedolizumab: <9.8 ng/mL
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
9 - 16 days
Test sent to Mayo Medical Laboratories.